Otsuka Holdings Co., Ltd. (TYO:4578)

Market Cap	5.51T +28.2%
Revenue (ttm)	2.47T +6.0%
Net Income	363.15B +5.8%
EPS	685.06 +8.1%
Shares Out	527.82M
PE Ratio	15.25
Forward PE	19.03
Dividend	140.00 (1.31%)
Ex-Dividend Date	Dec 29, 2025

Volume	460,100
Average Volume	1,392,985
Open	10,250
Previous Close	10,445
Day's Range	10,135 - 10,315
52-Week Range	6,465 - 10,910
Beta	-0.13
RSI	60.09
Earnings Date	Feb 13, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipme...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.